Advertisements
Year

During, Matthew J.

Ovid Therapeutics, United States

2022 Rank: 22836

Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:

Clinical Medicine

SubField 1:

Neurology & Neurosurgery

SubField 2:

Biotechnology

Rank in SubField 1: 1826 out of 305851 Researchers

Data For The Year: 2022
Metrics Self-Citations Excluded All
Rank Based on Composite Score2283623421
Total Cites1728920064
H-index6972
Hm-index2425
Number of Single Authored Papers77
Total Cites to Single Authored Papers8595
Number of Single+First Authored Papers3737
Total Cites to Single+First Authored Papers34373752
Number of Single+First+Last Authored Papers9898
Total Cites to Single+First+Last Authored Papers86409514
Composite Score33
Number of Distinct Citing Papers1424915738
Ratio of Total Citations to Distinct Citing Papers 1.21 1.27
Self-Citation Percentage
13.83%
Found an error in your data? Contact us with your profile link. Contact Us →

During, Matthew J.

Ovid Therapeutics, United States

2020 Rank: 20640

Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:

Clinical Medicine

SubField 1:

Neurology & Neurosurgery

SubField 2:

Biotechnology

Rank in SubField 1: 1694 out of 227881 Researchers

Data For The Year: 2020
Metrics Self-Citations Excluded All
Rank Based on Composite Score2064020845
Total Cites1561418203
H-index6671
Hm-index2324
Number of Single Authored Papers77
Total Cites to Single Authored Papers8090
Number of Single+First Authored Papers3737
Total Cites to Single+First Authored Papers32113509
Number of Single+First+Last Authored Papers9898
Total Cites to Single+First+Last Authored Papers80078823
Composite Score34
Number of Distinct Citing Papers1282514220
Ratio of Total Citations to Distinct Citing Papers 1.22 1.28
Self-Citation Percentage
14.22%
Found an error in your data? Contact us with your profile link. Contact Us →
Advertisements

Partner with TOPSCINET

Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.

Advertisements